Search

Your search keyword '"Habibian M"' showing total 307 results

Search Constraints

Start Over You searched for: Author "Habibian M" Remove constraint Author: "Habibian M"
307 results on '"Habibian M"'

Search Results

1. Effects of Barley Cultivar and Dietary Supplemental enzyme on Performance, Egg Quality Traits, and Selected Blood Parameters of Laying Hens

2. Effect of swimming training and arbutin supplement on cardiac antioxidant enzymes and oxidative stress in diabetic rats

3. Neuroprotective effect of aerobic training against Lead-induced oxidative stress in rat cerebellum

4. The comparison of acute aerobic and resistance training method on plasma fibrinogen concentration in young women

6. Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases

17. Re: Androgen-Deprivation Therapy Alone or with Docetaxel in Non-Castrate Metastatic Prostate Cancer (GETUG-AFU 15): A Randomised, Open-Label, Phase 3 Trial

18. Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

24. Acute ST elevation myocardial infarction early post orthotopic heart transplantation: A mechanistic dilemma.

25. Structural properties and gene-silencing activity of chemically modified DNA-RNA hybrids with parallel orientation

26. Protective Effect of Aerobic Exercise against Some of Proinflammatory Cytokines-Induced Chronic Nitric Oxide Synthase Inhibition in Renal Tissue Rats

36. Protective Effects of Regular Exercise Combined With Curcumin Supplementation Against Lead-Induced Cerebellar Oxidative Damage in an Animal Model

37. The attitudes of dental hygiene students toward unverserved populations

45. How should we treat castration-resistant prostate cancer patients who have received androgen deprivation therapy (ADT) plus docetaxel upfront for hormone-sensitive diseae? Mature analysis of the GETUG-AFU 15 phase III trial

46. Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP)

47. Modelling relapse in patients with high-risk localised prostate cancer treated randomly in the GETUG 12 phase III trial reveals two populations of relapsing patients

Catalog

Books, media, physical & digital resources